The U.K. is set to be the first country to allow over-the-counter sales of the erectile dysfunction drug Viagra, after the medication was reclassified.

Instead of going to see a doctor, men over the age of 18 will be able to obtain the drug after a conversation with a pharmacist. “Erectile dysfunction can be a debilitating condition, so it’s important men feel they have fast access to quality and legitimate care,” said Mick Foy of the Medicines and Healthcare products Regulatory Agency (MHRA), the body that made the decision. A four-pack of the drug, the formal name for which is Sildenafil, will cost around £20 ($27).

Pfizer, the U.S. pharmaceutical company that manufactures the drug, said it had plans to launch a non-prescription version of Viagra in spring 2018, according to Reuters.

The MRHA made the decision to deregulate the drug after a public consultation, and said it hoped the rule change would reduce the number of people buying counterfeit versions of the drug, which can be dangerous. The agency said that it had seized over £50m ($67m) of unlicensed and counterfeit erectile dysfunction medications in the past five years.

Get our Health Newsletter. Sign up to receive the latest health and science news, plus answers to wellness questions and expert tips. Please enter a valid email address. Sign Up Now Check the box if you do not wish to receive promotional offers via email from TIME. You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy . This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Thank you! For your security, we've sent a confirmation email to the address you entered. Click the link to confirm your subscription and begin receiving our newsletters. If you don't get the confirmation within 10 minutes, please check your spam folder.

Write to Billy Perrigo at billy.perrigo@time.com.